<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1085908</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Non-typeable <italic>Haemophilus influenzae</italic> major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Yu-Ching</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/556524"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kadari</surname>
<given-names>Mahendar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1957427"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Straw</surname>
<given-names>Megan L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1619994"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Janou&#x161;kov&#xe1;</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1587248"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonsson</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1790935"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thofte</surname>
<given-names>Oskar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/639175"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jalalvand</surname>
<given-names>Farshid</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matuschek</surname>
<given-names>Erika</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sandblad</surname>
<given-names>Linda</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/583003"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>V&#xe9;gv&#xe1;ri</surname>
<given-names>&#xc1;kos</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/966352"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zubarev</surname>
<given-names>Roman A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/216881"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Riesbeck</surname>
<given-names>Kristian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/28798"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Translational Medicine, Clinical Microbiology, Faculty of Medicine, Lund University</institution>, <addr-line>Malm&#xf6;</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>European Committee on Antimicrobial Susceptibility Testing (EUCAST) Development Laboratory, c/o Clinical Microbiology, Central Hospital</institution>, <addr-line>V&#xe4;xj&#xf6;</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry and The Laboratory for Molecular Infection Medicine Sweden (MIMS), Ume&#xe5; Centre for Microbial Research (UCMR), Ume&#xe5; University</institution>, <addr-line>Ume&#xe5;</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Division of Chemistry I, Department of Medical Biochemistry &amp; Biophysics (MBB), Proteomics Biomedicum, Karolinska Institute</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jes&#xfa;s A. Arenas, University of Zaragoza, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Natalia Korotkova, University of Kentucky, United States; Erwin Bohn, University of T&#xfc;bingen, Germany; Jeremy Derrick, The University of Manchester, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Kristian Riesbeck, <email xlink:href="mailto:kristian.riesbeck@med.lu.se">kristian.riesbeck@med.lu.se</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1085908</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Su, Kadari, Straw, Janou&#x161;kov&#xe1;, Jonsson, Thofte, Jalalvand, Matuschek, Sandblad, V&#xe9;gv&#xe1;ri, Zubarev and Riesbeck</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Su, Kadari, Straw, Janou&#x161;kov&#xe1;, Jonsson, Thofte, Jalalvand, Matuschek, Sandblad, V&#xe9;gv&#xe1;ri, Zubarev and Riesbeck</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Non-typeable <italic>Haemophilus influenzae</italic> (NTHi) is a Gram-negative human pathogen that causes a wide range of airway diseases. NTHi has a plethora of mechanisms to colonize while evading the host immune system for the establishment of infection. We previously showed that the outer membrane protein P5 contributes to bacterial serum resistance by the recruitment of complement regulators. Here, we report a novel role of P5 in maintaining bacterial outer membrane (OM) integrity and protein composition important for NTHi-host interactions. <italic>In silico</italic> analysis revealed a peptidoglycan-binding motif at the periplasmic C-terminal domain (CTD) of P5. In a peptidoglycan-binding assay, the CTD of P5 (P5<sup>CTD</sup>) formed a complex with peptidoglycan. Protein profiling analysis revealed that deletion of CTD or the entire P5 changed the membrane protein composition of the strains NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and NTHi 3655<italic>&#x394;p5</italic>, respectively. Relative abundance of several membrane-associated virulence factors that are crucial for adherence to the airway mucosa, and serum resistance were altered. This was also supported by similar attenuated pathogenic phenotypes observed in both NTHi 3655&#x394;<italic>p5</italic>
<sup>
<italic>CTD</italic>
</sup> and NTHi 3655&#x394;<italic>p5</italic>. We found (i) a decreased adherence to airway epithelial cells and fibronectin, (ii) increased complement-mediated killing, and (iii) increased sensitivity to the &#x3b2;-lactam antibiotics in both mutants compared to NTHi 3655 wild-type. These mutants were also more sensitive to lysis at hyperosmotic conditions and hypervesiculated compared to the parent wild-type bacteria. In conclusion, our results suggest that P5 is important for bacterial OM stability, which ultimately affects the membrane proteome and NTHi pathogenesis.</p>
</abstract>
<kwd-group>
<kwd>adherence</kwd>
<kwd>extracellular matrix</kwd>
<kwd>NTHI</kwd>
<kwd>P5</kwd>
<kwd>peptidoglycan</kwd>
<kwd>serum resistance</kwd>
<kwd>virulence</kwd>
</kwd-group>
<contract-sponsor id="cn001">Vetenskapsr&#xe5;det<named-content content-type="fundref-id">10.13039/501100004359</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Hj&#xe4;rt-Lungfonden<named-content content-type="fundref-id">10.13039/501100003793</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Knut och Alice Wallenbergs Stiftelse<named-content content-type="fundref-id">10.13039/501100004063</named-content>
</contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="69"/>
<page-count count="13"/>
<word-count count="5782"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Non-typeable <italic>Haemophilus influenzae</italic> (NTHi) is a Gram-negative coccobacillus and human-restricted opportunistic pathogen (<xref ref-type="bibr" rid="B13">Erwin and Smith, 2007</xref>). NTHi causes a wide range of mucosal infections in the upper and lower respiratory tract. This includes acute otitis media and exacerbations in patients with asthma and chronic obstructive pulmonary disease (<xref ref-type="bibr" rid="B33">Leibovitz et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B67">Van Eldere et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B61">Su et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B5">Brown et&#xa0;al., 2022</xref>). Several recent reports have also suggested NTHi in causing invasive diseases (<xref ref-type="bibr" rid="B67">Van Eldere et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B8">Carrera-Salinas et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B66">Tonnessen et&#xa0;al., 2022</xref>).</p>
<p>NTHi possesses a plethora of mechanisms to colonize while evading the host immune system for establishment of subsequent infection. The pathogen expresses a variety of virulence factors involved in: (i) acquisition of complement regulators (<italic>i.e.</italic>, C4b-binding protein (C4BP), vitronectin and factor H (FH)) to suppress complement-mediated killing, and (ii) adherence to host cell receptors (<italic>i.e.</italic>, CEACAMs and ICAM-1) and extracellular matrix proteins (<italic>i.e.</italic> fibronectin, laminin, vitronectin, and collagen IV) for colonization at the airway mucosa (<xref ref-type="bibr" rid="B22">Hill et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B17">Fink et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B2">Avadhanula et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B53">Ronander et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B27">Klaile et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B60">Su et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B32">Langereis et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B54">Rosadini et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B63">Su et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B62">Su et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). NTHi also occasionally harbours mutated penicillin-binding proteins (PBPs), produces &#x3b2;-lactamases and forms biofilm for antimicrobial resistance (<xref ref-type="bibr" rid="B64">Thegerstrom et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B21">Harrison et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B57">Shin et&#xa0;al., 2021</xref>).</p>
<p>One of the most studied virulence factors of NTHi is the major outer membrane (OM) protein 5 (P5). NTHi P5 is a ~35 kDa outer membrane protein (Omp) A family protein. It is composed of two main domains: (i) conserved N-terminal membrane-embedded &#x3b2;-barrel transmembrane domains with four highly variable and immunogenic extracellular surface loops (namely loop 1-4) and (ii) a conserved periplasmic C-terminal domain (CTD) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) (<xref ref-type="bibr" rid="B68">Webb and Cripps, 1998</xref>; <xref ref-type="bibr" rid="B43">Novotny and Bakaletz, 2003</xref>). The multifunctional surface loops of P5 contribute to NTHi adherence by binding to mucin, ICAM-1 and CEACAM1; and serum resistance by acquisition of C4BP and FH (<xref ref-type="bibr" rid="B48">Reddy et&#xa0;al., 1996</xref>; <xref ref-type="bibr" rid="B22">Hill et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B2">Avadhanula et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B32">Langereis et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B54">Rosadini et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). Even though the molecular structure of P5 has been extensively investigated in the aspect of host-pathogen interactions with focus on the extracellular loops, there is a paucity of information regarding the impact of periplasmic CTD of P5 in NTHi physiology and pathogenesis. Here we report a novel role of P5 in maintaining bacterial OM integrity and membrane protein composition important for NTHi-host interactions. Our findings provide useful knowledge regarding the direct and indirect role of P5 in the pathogenesis of NTHi.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>
<italic>In silico</italic> analysis and characterization of C-terminal domain (M233-K359) of P5 (P5<sup>CTD</sup>). <bold>(A)</bold> 3D-model of P5 from NTHi 3655 based on AlphaFold prediction (Identifier: AF-A0A0H3PCS3-F1) (upper panel). The N-terminal domain of P5 forms a transmembrane &#x3b2;-barrel embedded within the asymmetric lipid bilayer of the outer membrane, and is connected by a linker to a C-terminal domain (CTD) sitting inside the periplasm. Four loops (Loop 1-4) form extracellular structures of P5. For clearer visualization, individual loops are indicated with different colours. The topology of P5 is similar to OmpA proteins from <italic>E. coli</italic> and <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>). Linear structural features of P5 from NTHi 3655 (lower panel). CTD of P5 is located between residue M233 and K359. <bold>(B)</bold> Sequence alignment of the P5<sup>CTD</sup> with OmpA-like domains from other OmpA and Pal family proteins. Clustal Omega (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/clustalo/">https://www.ebi.ac.uk/Tools/msa/clustalo/</ext-link> ) was used to perform multiple sequence alignment. Residue D283 (green arrow) and R298 (orange arrow) are key residues in peptidoglycan binding (<xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>). Conserved residues are in pink shading, and similar residues are in grey shading. Red line indicates the region that mediates contact with the inner leaflet of the OM. Ec_Pal, peptidoglycan-associated lipoprotein (Pal) from <italic>Escherichia coli</italic> (GenBank accession number: P0A912); Bp_Pal, Pal from <italic>Burkholderia pseudomallei</italic> (Q63RA7); NTHi_P6, P6 from NTHi 3655 (P10324); Se_OmpA, OmpA from <italic>Salmonella typhimurium</italic> (ACY87707.1); Nm_RpmM, OmpA from <italic>Neisseria meningitidis</italic> (P0A0V3); Ec_OmpA, OmpA from <italic>E. coli</italic> (P0A910); Ab_OmpA, OmpA from <italic>Acinetobacter baumannii</italic> (Q6RYW5); NTHi_P5, P5 from NTHi 3655 (EDJ92910). <bold>(C)</bold> Purified His-tagged P5<sup>CTD</sup>, P6 and P4 of NTHi 3655 on Coomassie blue-stained 12% SDS-PAGE. <bold>(D)</bold> Peptidoglycan-binding assay of His-tagged P5<sup>CTD</sup>. Of note, all His-tagged proteins were pre-treated with a peptidoglycan-removal procedure prior to the peptidoglycan-binding assay (<xref ref-type="bibr" rid="B25">Karalus and Murphy, 1999</xref>). Purified proteins (3 &#x3bc;M) incubated with 100 &#xb5;g of peptidoglycan from <italic>E. coli</italic> K12 (+PG) were pelleted by ultracentrifugation. Supernatant (S) and pellet (P) were analysed by western blotting with HRP-conjugated anti-His pAb. Incubation without peptidoglycan (-PG) was included as a negative control. Lane C was loaded with just the His-tagged protein alone as an anti-His pAb detection control. Black arrows indicate the His-tagged proteins. M, protein marker in kDa (PageRuler&#x2122;, Prestained Protein Ladder, 10-250 kDa).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1085908-g001.tif"/>
</fig>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Bacterial strains and eukaryotic cells</title>
<p>
<italic>Escherichia coli</italic> DH5&#x3b1; (Stratagene, Santa Clara, CA) and BL21 (DE3) (Novagen, Darmstadt, Germany) were used as cloning and protein expression hosts, respectively. The genetic information and cultured conditions for <italic>E. coli</italic>, NTHi 3655 and the isogenic mutants are summarized in Supporting <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S1</bold>
</xref>. Construction of <italic>p5</italic>
<sup>CTD</sup>-knockout (NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>) and <italic>p5</italic>-transcomplementation (NTHi 3655&#x394;<italic>p5::p5</italic>) mutants is described in Supporting <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S2</bold>
</xref>. NTHi mutants were verified for surface display of P5 by flow cytometry using rabbit anti-peptide P5<sup>Loop3</sup> polyclonal antibodies (pAbs) (Genscript, Piscataway, NJ) (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). The human alveolar epithelial cell line A549 (ATCC CCL-185&#x2122;) (American Type Culture Collection (ATCC), Manassas, VA) was maintained in F12 medium supplemented with 2 mM L-glutamine, and 10% fetal calf serum (FCS) (Gibco, Life Technologies, Carlsbad, CA).</p>
</sec>
<sec id="s2_2">
<title>Isolation of membrane fractions and outer membrane vesicles</title>
<p>Bacterial membrane fractions and OMVs were isolated from mid and late-log phase cultures, respectively as described (<xref ref-type="bibr" rid="B62">Su et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B23">Jalalvand et&#xa0;al., 2022</xref>). Briefly, membrane fractions were pelleted from the supernatant of sonicated bacterial lysate at 150,000&#xd7;g at 4&#xb0;C for 1 hour. Bacterial lysates or membrane fractions were separated on 12% SDS-PAGE followed by western blotting. Anti-peptide P5<sup>Loop3</sup> pAb and horse radish peroxidase (HRP)-conjugated donkey anti-rabbit pAb (Abcam, Cambridge, UK) were used to detect P5 on the blots (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). The OM fractions (from three replicated preparations) were subjected to proteomic analysis (Proteomics Biomedicum, Karolinska Institutet, Sweden) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S3</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supporting Methodology</bold>
</xref>). The yield and particle size of purified OMVs were determined by nanoparticle tracking analysis (NTA) with a NanoSight NS300 (Malvern Panalytical, Malvern, UK).</p>
</sec>
<sec id="s2_3">
<title>Recombinant protein expression</title>
<p>DNA fragment encoding P5<sup>CTD</sup> (M233 to K359) was amplified from plasmid P5<sup>3655</sup>-pET16b (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>) using specific primers (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S2</bold>
</xref>) and cloned into the expression vector pET26(b)+ (Novagen). His-tagged recombinant protein was expressed in <italic>E. coli</italic> BL21 (DE3) with 1 mM IPTG induction and purified as described (<xref ref-type="bibr" rid="B60">Su et&#xa0;al., 2013</xref>).</p>
</sec>
<sec id="s2_4">
<title>Peptidoglycan-binding assay</title>
<p>The assay was performed as described (<xref ref-type="bibr" rid="B15">Fan et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>). Briefly, 3 &#xb5;M of His-tagged recombinant protein was incubated with 100 &#xb5;g of peptidoglycan from <italic>E. coli</italic> K12 (Invivogen, Toulouse, France) in 100 &#xb5;l of ice-cold binding buffer (10 mM Tris-Cl, 10 mM MgCl<sub>2</sub>, 50 mM NaCl, pH6.8) at 4&#xb0;C for 16 hours. Mixtures were pelleted at 350,000&#xd7;g at 4&#xb0;C for 1 hour. The supernatants were collected as unbound protein; the pellets were washed twice with the ice-cold binding buffer. Finally, the pellets were dissolved in 2% SDS. The supernatants and pellets were analysed on 12% SDS-PAGE and western blotting. His-tagged proteins were detected with HRP-conjugated anti-His pAb (Abcam).</p>
</sec>
<sec id="s2_5">
<title>Adherence assay</title>
<p>Bacterial adherence to human epithelial cells was performed as described (<xref ref-type="bibr" rid="B63">Su et&#xa0;al., 2016</xref>). Briefly, cells grown to 85% confluency were infected with mid-log phase bacteria (OD<sub>600</sub> = 0.5) to achieve a multiplicity of infection (MOI) of 100, at 37&#xb0;C and 5% CO<sub>2</sub> in F12 media without FCS for 30 min. Cells were washed with PBS and detached with trypsin-EDTA (Sigma-Aldrich, St. Louis, MO). Cell solutions were plated on chocolate agar and incubated at 37&#xb0;C and 5% CO<sub>2</sub> for 16 hours to quantify adherent bacteria in colony-forming units (CFU).</p>
</sec>
<sec id="s2_6">
<title>Fibronectin-binding assay</title>
<p>The assay was performed by flow cytometry as described (<xref ref-type="bibr" rid="B62">Su et&#xa0;al., 2019</xref>). Mid-log phase (OD<sub>600</sub> = 0.5) bacteria (5&#xd7;10<sup>7</sup> CFU) were incubated with indicated concentrations of human fibronectin (Sigma-Aldrich) in 100 &#xb5;l of 1% BSA at 37&#xb0;C and 5% CO<sub>2</sub> for 1 hour. Samples were washed and pelleted by centrifugation. Bacteria-bound fibronectin was detected with rabbit anti-human fibronectin pAb (Dako, Glostrup, Denmark) and FITC-conjugated swine anti-rabbit pAb (Dako). Samples were analysed in a BD FACSVerse&#x2122; flow cytometer (Becton-Dickinson, Franklin Lakes, NJ).</p>
</sec>
<sec id="s2_7">
<title>Serum resistance assay</title>
<p>The assay was performed as described (<xref ref-type="bibr" rid="B60">Su et&#xa0;al., 2013</xref>). Suspension of mid-log phase (OD<sub>600</sub> = 0.5) bacteria (1.5&#xd7;10<sup>3</sup> CFU) in 150 &#xb5;l of DVBS-BSA buffer was incubated with 5% normal human serum (NHS) for indicated time points at 37&#xb0;C. Samples were plated on chocolate agar and incubated at 37&#xb0;C and 5% CO<sub>2</sub> for 16 hours.</p>
</sec>
<sec id="s2_8">
<title>Hyperosmotic assay</title>
<p>The assay was performed as described (<xref ref-type="bibr" rid="B39">Mychack et&#xa0;al., 2019</xref>). Bacteria grown to mid-log phase (OD<sub>600</sub> = 0.5) were pelleted, washed, and resuspended in PBS to OD<sub>60</sub> = 1.0. Bacterial suspensions were 10-fold serially diluted in PBS to generate 10<sup>4</sup>-10<sup>9</sup> CFU/ml, and 2 &#xb5;l from each dilution was spotted on chocolate agar supplemented with 50 mM or 100 mM NaCl. Plates were incubated at 37&#xb0;C and 5% CO<sub>2</sub> for 16 hours.</p>
</sec>
<sec id="s2_9">
<title>Broth microdilution</title>
<p>Broth microdilution (BMD) was performed in three independently repeated-experiments according to ISO 20776-1 on custom freeze-dried Sensititre plates (Thermo Scientific, Basingstoke, UK) using the EUCAST recommended broth for fastidious organisms (Mueller Hinton Fastidious (MH-F) broth) to estimate minimal inhibitory concentrations (MICs) of antibiotics. MIC endpoints after 16-20 hours of incubation at 35 &#xb1; 1&#xb0;C were visually evaluated according to ISO and EUCAST recommendations.</p>
</sec>
<sec id="s2_10">
<title>Statistical analyses</title>
<p>We used GraphPad Prism<sup>&#xae;</sup> 9.0 (GraphPad Software, La Jolla, CA) for statistical analyses. One- or two-way ANOVA tests were used as indicated. Differences were considered statistically significant at <italic>P &#x2264;</italic> 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>The periplasmic C-terminal domain of P5 binds peptidoglycan</title>
<p>Based on bioinformatic analysis, P5 of NTHi 3655 belongs to the OmpA family of proteins (InterPro entry number: IPR002368) (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2</bold>
</xref>). An OmpA-like domain (IPR006665) was found at the C-terminal domain (CTD) of P5 (P5<sup>CTD</sup>) that was located between residue M233 and K359. The P5<sup>CTD</sup> shared 20.6-56.2% of sequence similarity (34.6-67.2% identity) with some peptidoglycan-associated lipoproteins (Pal) and the C-terminus of other OmpA proteins that are known to have an OmpA-like domain, and experimentally bind peptidoglycan (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). While the protein sequence homology of CTDs among OmpA family proteins is generally poor, two key residues (<italic>i.e.</italic>, D283 and R298) that were crucial for peptidoglycan binding of OmpA in <italic>Acinetobacter baumannii</italic> and <italic>E. coli</italic> were also found on the P5<sup>CTD</sup> (<xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>).</p>
<p>The OmpA-like domain has a peptidoglycan-binding property <italic>via</italic> non-covalent interactions (<xref ref-type="bibr" rid="B20">Hancock et&#xa0;al., 1994</xref>; <xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>). We therefore hypothesize that P5 also might function in an OmpA-like domain-dependent peptidoglycan binding. We observed that purified His-tagged P5<sup>CTD</sup> formed a complex with peptidoglycan, which was almost comparable to His-tagged P6 (positive control) (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C, D</bold>
</xref>). P6 is a Pal with an OmpA-like domain and is known to bind peptidoglycan in NTHi (<xref ref-type="bibr" rid="B25">Karalus and Murphy, 1999</xref>; <xref ref-type="bibr" rid="B4">Berenson et&#xa0;al., 2005</xref>). P6 does not have a transmembrane beta-barrel domain as seen in OmpA. The negative control, His-tagged P4 of NTHi 3655 (<xref ref-type="bibr" rid="B26">Kemmer et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B63">Su et&#xa0;al., 2016</xref>) did not bind peptidoglycan. Taken together, our data demonstrates that the P5<sup>CTD</sup> has a peptidoglycan-binding activity as predicted by <italic>in silico</italic> analysis thus may play a role in the OM integrity of NTHi.</p>
</sec>
<sec id="s3_2">
<title>Deletion of P5 leads to altered membrane proteome composition in NTHi</title>
<p>The OmpA-like domain serves as an anchor between the OM layer and the peptidoglycan. The interaction is crucial for OM-cell wall stability, and the assembly of membrane and cell wall proteins (<xref ref-type="bibr" rid="B20">Hancock et&#xa0;al., 1994</xref>; <xref ref-type="bibr" rid="B28">Knowles et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B7">Calmettes et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B44">Ortiz-Suarez et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B18">Graham et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B35">Mamou et&#xa0;al., 2022</xref>). Since we showed that P5<sup>CTD</sup> of NTHi 3655 has peptidoglycan-binding activity, we hypothesized a possible role for P5 in the distribution of NTHi periplasmic and membrane protein (membrane proteome). To this end, we generated NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> that expressed CTD-deleted P5, and a P5-transcomplemented mutant (NTHi 3655&#x394;<italic>p5::p5</italic>). In addition, NTHi 3655&#x394;<italic>p5</italic> that has a full deletion of P5 was included as a control for comparison to the deletion of P5<sup>CTD</sup> (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>).</p>
<p>Comparative SDS-PAGE of bacterial whole cell lysates and membrane fractions revealed some differences in the intensity of a few protein bands among the NTHi 3655 wild-type and mutants (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> exhibited a roughly similar pattern of protein profiling; while a simpler similarity of protein profiling pattern was observed between the wild-type and &#x394;<italic>p5::p5</italic>. In western blotting, wild-type P5 and CTD-truncated P5 were detected by anti-P5<sup>Loop3</sup> pAb in NTHi 3655 and &#x394;<italic>p5<sup>CTD</sup>
</italic>, respectively. This indicated that the deletion of CTD did not hamper protein expression of the remaining extracellular-loops and the transmembrane parts of P5 in NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>. Any corresponding signal was not detected in NTHi 3655&#x394;<italic>p5</italic> that was used as a negative control. Interestingly, we observed reduced detection of P5 on the surface of &#x394;<italic>p5<sup>CTD</sup>
</italic> compared to the wild-type by flow cytometry analyses (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). The signal was, however, higher than the P5-knockout mutant, suggesting partial or reduced exposure of P5 extracellular structures on the surface of &#x394;<italic>p5<sup>CTD</sup>
</italic>. Unexpectedly, &#x394;<italic>p5::p5</italic> also exhibited partial detection of P5 by flow cytometry compared to the wild-type. It is currently unclear what causes the partial exposure of P5 extracellular structures in &#x394;<italic>p5::p5</italic>; it is not known if there are any spontaneous genetic mutations that could affect periplasmic post-translational modifications essential for OM insertion of P5 (<xref ref-type="bibr" rid="B9">Chen and Henning, 1996</xref>; <xref ref-type="bibr" rid="B58">Sklar et&#xa0;al., 2007</xref>). Since the transcomplemented strain could not fully restore the surface expression of P5, this strain was excluded from downstream experiments.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Characterization of protein profiles of NTHi 3655 wild-type and isogenic mutants. Analysis of <bold>(A)</bold> whole cell lysates (1&#xd7;10<sup>7</sup> CFU per lane) and <bold>(B)</bold> membrane fractions (20 &#xb5;g per lane) of NTHi 3655 wild-type and isogenic mutants on a Coomassie-blue stained 12% SDS-PAGE (left panel) and western blotting (right panel). In western blotting, wild-type P5 (full length) was detected as two signal bands of ~28 kDa and 36 kDa (indicated by black arrows) from the whole cell lysate (panel A), and membrane fraction (panel B) of NTHi 3655 wild-type and NTHi 3655&#x394;<italic>p5::p5</italic>. Wild-type P5 of NTHi appears as two isoforms (~28 kDa and 36 kDa) on SDS-PAGE due to heat denaturation of protein at 85&#xb0;C during sample preparation (<xref ref-type="bibr" rid="B51">Roier et&#xa0;al., 2012</xref>). In NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>, P5 with CTD deletion was detected as a signal band of ~25 kDa (indicated with red arrows) in western blotting (right panels of <bold>A</bold>, <bold>B</bold>). We did not identify any western blotting signal of P5 in the NTHi 3655&#x394;<italic>p5.</italic> Blue arrows in panel <bold>(B)</bold> indicate protein bands in membrane fractions that have different levels of intensities on SDS-PAGE compared to the NTHi 3655 wild-type. <bold>(C)</bold> Flow cytometry analysis of detection of P5 extracellular structures on the bacterial surface. Bacteria from mid-log phase (OD<sub>600 </sub>= 0.5) were washed and resuspended in PBS containing 1% BSA. A bacterial suspension containing 5&#xd7;10<sup>7</sup> CFU in 20 &#xb5;l were incubated with rabbit anti-P5<sup>Loop3</sup> pAb for 30 min (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). Samples were thereafter washed followed by incubation with FITC-conjugated goat anti-rabbit IgG, and finally analyzed on a BD FACSVerse flow cytometer. For antibody background control, samples were stained with the FITC-conjugated secondary antibody only. A representative data from three independent experiments is shown. Median values of fluorescence intensity are indicated for each sample. FlowJo v10 software (BD, Williamson Way Ashland, OR) was used for data presentation. Rabbit anti-P5<sup>Loop3</sup> pAb targeting extracellular loop 3 of P5 was used in western blot <bold>(A, B)</bold> and flow cytometry <bold>(C)</bold> (<xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>). WT, wild-type NTHi 3655; &#x394;<italic>p5</italic>, <italic>p5</italic>-knockout mutant (NTHi 3655&#x394;<italic>p5</italic>); &#x394;<italic>p5<sup>CTD</sup>
</italic>, mutant expressing P5 without CTD (NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>); &#x394;<italic>p5::p5, p5-</italic>transcomplemented NTHi (NTHi 3655&#x394;<italic>p5::p5</italic>). M, protein marker (PageRuler&#x2122; Prestained Protein Ladder, 10 to 250 kDa).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1085908-g002.tif"/>
</fig>
<p>To globally understand how P5 is involved in regulating membrane protein organization, we primarily focused on analysing the proteomic composition of the membrane from &#x394;<italic>p5</italic> and compared with the wild-type strain. The bacterial membrane preparations used in this study contained mainly OM and periplasmic proteins. Based on the ranking of relative abundance, virulence factors such as major adhesins (<italic>i.e.</italic>, High molecular weight adhesin (HMW) and <italic>Haemophilus</italic> adhesin protein (Hap)) and IgA protease were less represented while P2, PD, PF and PE were more abundant in the P5-knockout mutant, with respect to the wild-type strain (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S3</bold>
</xref>) (<xref ref-type="bibr" rid="B11">Duell et&#xa0;al., 2016</xref>). We also noticed that periplasmic chaperones (SurA, Omp26 and DegP) and Bam complex subunit proteins (BamA, C, D and E) that are essential for proper folding and assembly of OM proteins, respectively, were less abundant in the mutant (<xref ref-type="bibr" rid="B28">Knowles et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B7">Calmettes et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B35">Mamou et&#xa0;al., 2022</xref>).</p>
<p>In conclusion, our results suggest that P5 has an influence on the proteomic composition of OM and periplasm in NTHi. P5 may help to maintain optimal interactions between the OM layer and the periplasmic peptidoglycan network that is crucial for cell envelope integrity and protein assembly.</p>
</sec>
<sec id="s3_3">
<title>NTHi expressing CTD-deleted P5 exhibits reduced adherence to pulmonary epithelial cells and extracellular matrix protein, and is serum sensitive</title>
<p>The aberrant membrane proteome composition in NTHi upon the deletion of P5 is likely to affect some cellular functions that are crucial for NTHi pathogenesis (<xref ref-type="bibr" rid="B13">Erwin and Smith, 2007</xref>; <xref ref-type="bibr" rid="B11">Duell et&#xa0;al., 2016</xref>). Previous studies have shown that P5 deletion in different NTHi isolates results in defective adherence to host cells and increased serum sensitivity compared to the P5-expressing NTHi (<xref ref-type="bibr" rid="B22">Hill et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B54">Rosadini et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B14">Euba et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B69">Wong et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>).</p>
<p>Considering that NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> has a reduced exposure of P5 on the surface while showing almost similar membrane profiling on SDS-PAGE as the NTHi 3655&#x394;<italic>p5</italic>, we wanted to investigate whether the P5<sup>CTD</sup> truncation could also affect bacterial pathogenicity in a similar fashion as when P5 was fully deleted.</p>
<p>We therefore tested the bacteria by <italic>in vitro</italic> functional assays related to adherence to host epithelial cells and evasion of host immune system since these two mechanisms are crucial for NTHi persistence to establish infection in the respiratory tract (<xref ref-type="bibr" rid="B11">Duell et&#xa0;al., 2016</xref>). The adherence of NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> to the lower airway A549 epithelial cells and extracellular matrix protein (fibronectin) was almost comparable to NTHi 3655&#x394;<italic>p5</italic>, which were significantly (<italic>P &#x2264;</italic> 0.001) reduced compared to the NTHi 3655 wild-type (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). When exposed to 5% NHS for 10 min, deletion of P5<sup>CTD</sup> rendered the &#x394;<italic>p5<sup>CTD</sup>
</italic> mutant to be more serum sensitive compared to the wild-type (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). However, the &#x394;<italic>p5<sup>CTD</sup>
</italic> mutant survived better (53% of survival) than the NTHi 3655&#x394;<italic>p5</italic> which was almost fully killed (1.9% survival) when exposed to NHS. The data confirm that deletion of P5<sup>CTD</sup> could impair NTHi pathogenicity similarly as the full deletion of P5. We concluded that P5<sup>CTD</sup> has an important impact on bacterial pathogenesis.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Analysis of bacterial pathogenic phenotypes and membrane stability. <bold>(A)</bold> Bacterial adherence to human type II alveolar epithelial cells (A549) at multiplicity of infection (MOI) of 100 for 30 min. Mean data from three independent experiments (biological replicates) is presented. Bacterial adherence was presented as percentage of CFU recovered per well relative to initial inoculum. <bold>(B)</bold> Binding of NTHi 3655 wild-type and mutants to human fibronectin. Bacterial (5&#xd7;10<sup>7</sup> CFU) binding to human fibronectin (0.8-2.0 &#xb5;g/ml) in 100 &#xb5;l reactions was analysed by flow cytometry after incubation for 1 hour at 37&#xb0;C. Rabbit anti-human fibronectin and FITC-conjugated swine anti-rabbit pAbs were used to detect the bacterial-bound fibronectin. Data represent mean values of three independent experiments. <bold>(C)</bold> Serum killing of NTHi 3655 wild-type and mutants. Bacterial (1.5&#xd7;10<sup>3</sup> CFU) killing by 5% NHS was analysed by CFU count on chocolate agar. Heat-inactivated serum was included as a negative control and here no bacteria were killed (data not shown). Percentage of bacterial survival was expressed as (T<sub>t</sub> CFU/T<sub>0</sub> CFU)&#xd7;100. T<sub>0</sub> represents CFU of sample plated at 0 min; and Tt represents CFU of sample plated at indicated time points. Data represent mean values of three independent experiments. <bold>(D)</bold> Outer membrane vesicles (OMVs) production among NTHi 3655 wild-type and mutants. OMVs from bacterial cultures were sucrose-density gradient purified and subjected to nanoparticle tracking analysis with a NanoSight NS300. OMV samples were diluted in PBS until 20-120 particles per frame were archived. Settings were optimized using 100nm polystyrene beads, and samples were recorded using the same settings (camera level 12, three recordings of 30 sec each). Recordings were thereafter processed using the NanoSight 3.1 software. Data represents mean values from three independent experiments. <bold>(E)</bold> Spot viability assay of bacterial survival in response to hyperosmotic environment. Bacteria that were serially diluted (10<sup>9</sup> to 10<sup>4</sup> CFU/ml) was spotted on chocolate agar without sodium chloride (NaCl) (left panel) or supplemented with 50 mM (middle panel) and 100 mM NaCl (right panel). Images were captured using ProtoCOL 3 HD (Synbiosis, UK). The assay was repeated in three independent experiments, and images from a representative experiment were shown. For panel A-D, error bars indicate standard deviations. Differences between wild-type and mutants were calculated by one-way ANOVA for panel <bold>(A, D)</bold>; and two-way ANOVA for panel <bold>(B, C)</bold> *, <italic>P &#x2264;</italic> 0.05; **, <italic>P &#x2264;</italic> 0.01; ***, <italic>P &#x2264;</italic> 0.005; ****, <italic>P &#x2264;</italic> 0.001. WT, NTHi 3655 wild-type; &#x394;<italic>p5</italic>, <italic>p5</italic>-knockout mutant (NTHi 3655&#x394;<italic>p5</italic>); &#x394;<italic>p5<sup>CTD</sup>
</italic>, mutant expressing P5 without CTD (NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>); &#x394;<italic>p5::p5, p5-</italic>transcomplemented NTHi (NTHi 3655&#x394;<italic>p5::p5</italic>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1085908-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants are hypervesiculating and have compromised membrane integrity</title>
<p>Gram-negative bacteria with genetic knockouts of OmpA-like domain superfamily proteins (InterPro: IPR036737) are unable to establish bonds between the OM and peptidoglycan, leading to increased release of OMVs (<xref ref-type="bibr" rid="B3">Avila-Calderon et&#xa0;al., 2021</xref>). To evaluate whether the deletion of either CTD or full length P5 could affect the vesiculation of NTHi, naturally released OMVs were purified from the late-log phase bacterial culture and normalized by cell density. Both NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> produced extensive amounts of OMVs as compared to the NTHi 3655 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). Interestingly, NTHi 3655&#x394;<italic>p5</italic> was the most hypervesiculating strain, producing almost 2-fold more OMVs than the &#x394;<italic>p5<sup>CTD</sup>
</italic> mutant (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
<p>The increased OMV production suggested an OM instability among the &#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants. To test this hypothesis, we performed an osmotic shock assay by growing bacteria on chocolate agar supplemented with different NaCl concentrations. When cultured on chocolate agar without additional NaCl or supplemented with 50 mM NaCl, similar to the wild-type, NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants did not show any growth defect (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). However, at a higher NaCl concentration (100 mM), NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants were equally sensitive to the high salt hence showed defective growth, compared to the wild-type. In line with these results, the &#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants equally displayed a 2- and 4-fold susceptibility to &#x3b2;-lactam antibiotics ampicillin (MIC=0.12 &#xb5;g/ml) and imipenem (0.12 &#xb5;g/ml), respectively compared to NTHi 3655 (MIC=ampicillin 0.25 &#xb5;g/ml; imipenem 0.5 &#xb5;g/ml). Collectively, our data indicate that the CTD of P5 is important in maintaining OM stability and integrity, hence bacterial vesiculation and beta-lactam antibiotics resistance.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The OmpA-like domain has been extensively studied at the molecular level for OmpA homologs in several pathogens including <italic>E. coli, A. baumannii, Vibrio cholerae, Neisseria meningitidis</italic>, and <italic>Salmonella enterica</italic>. It was shown to contribute to cell envelope stability by forming non-covalent linkages between the OM and peptidoglycan network (<xref ref-type="bibr" rid="B24">Jin et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B38">Moon et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B36">Marcoux et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>). In contrast, the relevance of OmpA-like domain of P5 in NTHi cell envelope physiology hence pathogenesis has not yet been addressed. Bioinformatics analysis in combination with <italic>in vitro</italic> peptidoglycan-binding assays revealed the presence of the  OmpA-like domain at the C-terminal of P5 that was proven to be active in forming a complex with the peptidoglycan (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). While the mechanism of the P5<sup>CTD</sup>-peptidoglycan interaction remains to be experimentally elucidated, we postulate that residues D283 and R298 of P5 might interact with the mDAP residue from the peptidoglycan. Ten residues (A313-A343) from the peptidoglycan-bound P5<sup>CTD</sup> will then interact with the lipid group of the inner leaflet of OM. This in turn stabilizes the P5<sup>CTD</sup> for stronger interaction with the peptidoglycan while enabling peptidoglycan to further interact with the OM. In general, P5 functions as an anchor to tether the OM to the underlying peptidoglycan, ensuring optimal periplasmic distance between the outer and inner membrane. This architecture stabilizes the OM on the NTHi cell envelope (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>), as previously described for the OmpA-peptidoglycan models from <italic>A. baumannii</italic> and <italic>E. coli</italic> (<xref ref-type="bibr" rid="B45">Park et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>). Our postulation is based on two rationales: (i) the annotation of D283 and R298 in P5<sup>CTD</sup> that are also the key residues in <italic>A. baumannii</italic> OmpA for peptidoglycan binding; and (ii) the sequence similarity between the A313-A343 of P5<sup>CTD</sup> (71% similarity; 74.2% identity) and the OM&#x2019;s inner leaflet-binding domain of <italic>E. coli</italic> OmpA (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Graphical summary of the role of P5 in regulating outer membrane (OM) stability and distribution of surface virulence factors. Peptidoglycan-associated lipoprotein P6 together with P5 bind peptidoglycan <italic>via</italic> the OmpA-like domain (upper panel). The CTD of P5 will also interact with the inner leaflet of the OM, this will lead to stable contact between the OM and peptidoglycan. Meanwhile, TolAQRB-P6 complex joins the inner membrane with the peptidoglycan. The multiple linkages aid in the stability of NTHi cell envelope, subsequently provide an optimal membrane platform for the assembly and display of various surface virulence factors such as HMW, Hap, P4 and LOS, to name a few. However, interruption or deletion of proteins with OmpA-like domain involved in peptidoglycan binding will decrease the number of linkages or bonds between the OM and the peptidoglycan (lower panel). This will lead to OM protrusion, and increased vesiculation. The OM layer will become more permeable to solutes or antibiotics. The disrupted or collapsed OM will also hamper the translocation and assembly of various membrane proteins at bacterial surface, indirectly reducing bacterial interactions with the human host.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1085908-g004.tif"/>
</fig>
<p>To the best of our knowledge, this is the first report in deciphering the dynamics of the P5-dependent NTHi membrane proteome. Interestingly, the aberrant protein compositions in the bacterial membrane in response to P5 deletion or truncation of P5<sup>
<italic>CTD</italic>
</sup> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Table S3</bold>
</xref>) did not alter bacterial cell morphology neither defect bacterial growth (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3</bold>
</xref>). Instead, it was more associated with a reduced pathogenic phenotype as seen in NTHi 3655&#x394;<italic>p5</italic> and to some extent, NTHi 3655&#x394;<italic>p5</italic>
<sup>
<italic>CTD</italic>
</sup> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). In previous reports, deletion of proteins involved in the OM and cell wall physiology (<italic>i.e.</italic>, VacJ, YcrB and EnvC) of NTHi also resulted in altered membrane proteome, causing the <italic>vac</italic>J, <italic>ycr</italic>B and <italic>env</italic>C-knockout mutants to be serum sensitive, attenuated in adherence and biofilm formation, and are hypervesiculating (<xref ref-type="bibr" rid="B12">Ercoli et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B52">Roier et&#xa0;al., 2016</xref>). We speculate that the reduced appearance of periplasmic chaperones (SurA, Omp26, and DegP) and BamACDE complex in the P5-knockout mutant could probably impair the maturation, and degradation of some misfolded proteins. This ultimately led to the accumulation of some OM proteins in the periplasm or the OM. This might explain the increased abundance of P2 in NTHi 3655&#x394;<italic>p5</italic>, which was probably in an unfolded/misfolded state. The impaired membrane protein assembly machineries could also affect the presentation of autotransporters (<italic>i.e.</italic>, Hap and HMW), or &#x3b2;-barrel membrane protein like CTD-deleted P5 on the surface of NTHi 3655&#x394;<italic>p5</italic> and NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>, respectively. Further experimental investigation is, however, needed to unveil the molecular mechanism on how P5 or P5<sup>CTD</sup> deletion could globally alter the expression level, and protein folding state of certain membrane proteins.</p>
<p>The proteomic characterization of the  bacterial membrane of NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> is currently ongoing, and the results will be part of a follow-up study. Therefore, besides the reduced exposure of surface P5 extracellular loops, we are currently unable to define the exact additional factors that might contribute to the NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> altered pathogenic phenotypes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). We speculated that the partial exposure of P5 extracellular structures on the surface NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> could be associated with the deletion of CTD of P5 in addition to other unknown factors, suggesting that the P5<sup>
<italic>CTD</italic>
</sup> might play a role in the OM insertion of P5. In <italic>E. coli</italic>, OM assembly of OmpA partly depends on the periplasmic post-translational modifications on the CTD, including hydrophobicity modification by oligo-(<italic>R</italic>)-3-hydroxybutyrates and disulphide bond formation between residues C311 and C323 (<xref ref-type="bibr" rid="B46">Patel et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B47">Qu et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B40">Negoda et&#xa0;al., 2010a</xref> <xref ref-type="bibr" rid="B41">; Negoda et al., 2010b</xref>). Nevertheless, the proteomic data of NTHi 3655&#x394;<italic>p5</italic> will be used as a reference for NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> in this study, considering their almost similar protein profiling on SDS-PAGE (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). In addition to the absence of P5 on the bacterial surface, the decreased abundance of Hap and HMW might partly contribute to the reduced adherence of NTHi 3655&#x394;<italic>p5</italic>, and probably also for NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic>, to the host epithelial cells (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2</bold>
</xref>, <xref ref-type="fig" rid="f3">
<bold>3</bold>
</xref>) (<xref ref-type="bibr" rid="B42">Noel et&#xa0;al., 1994</xref>; <xref ref-type="bibr" rid="B22">Hill et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B14">Euba et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B1">Atack et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B16">Fernandez-Calvet et&#xa0;al., 2021</xref>). However, the reduced fibronectin binding among the mutants could be mainly attributed to the decreased density of Hap (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). This is because Hap has been known as the major fibronectin-binding protein in NTHi but not the P5 (<xref ref-type="bibr" rid="B17">Fink et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B63">Su et&#xa0;al., 2016</xref>). Moreover, the presence of P4, PF and PE did not improve the bacterial adherence, fibronectin binding, and serum resistance of NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> (<xref ref-type="bibr" rid="B19">Hallstrom et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B53">Ronander et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B60">Su et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B63">Su et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B62">Su et&#xa0;al., 2019</xref>). The reduced exposure of P5 loops on the bacterial surface of NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> might reduced the recruitment of C4BP and FH hence increased sensitivity to serum killing (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>), as previoulsy reported for P5-knockout mutants (<xref ref-type="bibr" rid="B32">Langereis et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B54">Rosadini et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B65">Thofte et&#xa0;al., 2021</xref>).</p>
<p>Lipooligosaccharide (LOS) biosynthesis and assembly are related to protein assembly on the OM (<xref ref-type="bibr" rid="B50">Ried et&#xa0;al., 1990</xref>; <xref ref-type="bibr" rid="B6">Bulieris et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B59">Spahich et&#xa0;al., 2014</xref>). Hence, full P5 deletion might also potentially affect the assembly of LOS and the exposure of surface immunogenic antigens, however, with greater impact than the partial deletion of P5. This might cause the LOS and surface antigens of NTHi3655&#x394;<italic>p5</italic> to be more accessible to C-reactive protein or antibodies from NHS (<xref ref-type="bibr" rid="B10">Clark et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B51">Roier et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B31">Langereis et&#xa0;al., 2019</xref>), hence more complement-mediated killing of NTHi 3655&#x394;<italic>p5</italic> than the &#x394;<italic>p5<sup>CTD</sup>
</italic>. This postulation remains, however, to be experimentally elucidated.</p>
<p>The loss of OM integrity was most likely caused by the absence of P5<sup>CTD</sup> in both NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> mutants, leading to hypervesiculation while defective in protecting bacteria from a hyperosmotic environment (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f4">
<bold>4</bold>
</xref>) (<xref ref-type="bibr" rid="B3">Avila-Calderon et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B18">Graham et&#xa0;al., 2021</xref>). Despite P6 being present in &#x394;<italic>p5</italic> and probably also in &#x394;<italic>p5<sup>CTD</sup>
</italic>, with equal abundance as in the wild-type (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S3</bold>
</xref>), P6 alone was not sufficient to maintain the linkage between the OM and peptidoglycan without the P5<sup>CTD</sup>. In <italic>E. coli</italic>, co-interactions among Braun&#x2019;s lipoprotein, OmpA and peptidoglycan are essential in OM stability and integrity to protect bacterial cells from high internal osmotic pressure (<xref ref-type="bibr" rid="B56">Samsudin et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B55">Samsudin et&#xa0;al., 2017</xref>). Decreased expression of PBP has also been associated with bacterial resistance against &#x3b2;-lactam antibiotics (<xref ref-type="bibr" rid="B49">Reygaert, 2018</xref>; <xref ref-type="bibr" rid="B30">Kyriakidis et&#xa0;al., 2021</xref>). It is possible that the increased abundance of PBP3 and the compromised OM might promote killing of NTHi 3655&#x394;<italic>p5<sup>CTD</sup>
</italic> and &#x394;<italic>p5</italic> by ampicillin and imipenem (<xref ref-type="bibr" rid="B34">Makover et&#xa0;al., 1981</xref>; <xref ref-type="bibr" rid="B37">Mendelman et&#xa0;al., 1990</xref>). A mutant of <italic>A. baumannii</italic> expressing OmpA without an OmpA-like domain (homolog of P5<sup>CTD</sup>) was also more susceptible to imipenem compared to the wild-type strain (<xref ref-type="bibr" rid="B29">Kwon et&#xa0;al., 2017</xref>).</p>
<p>In conclusion, our study sheds light upon the novel role of P5 which is important in regulating NTHi membrane integrity <italic>via</italic> the OmpA-like domain. The P5<sup>CTD</sup> has an impact on the distribution of the OM proteins including a plethora of virulence factors, hence NTHi pathogenesis in general.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>YCS, MK and KR coordinated the manuscript. YCS and KR drafted the manuscript. AV and RZ performed proteomic analysis. MK and FJ constructed mutants and analysed bacterial protein profiles on SDS-PAGE. MK and OT worked on OMVs preparation and analysis. MS performed bacterial fibronectin-binding assays. YCS and MK carried out bacterial adherence and hyperosmotic assays. MJ conducted surface detection of P5. SJ did bacterial serum resistance assay and growth curve study. LS analysed bacterial cell morphology on TEM. and BMD was done by EM. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the Knut and Alice Wallenberg Foundation (KR; 2018.0318), Anna and Edwin Berger Foundation (KR), Swedish Heart Lung Foundation (KR; #20180401, <ext-link ext-link-type="uri" xlink:href="http://www.hjart-lungfonden.se">www.hjart-lungfonden.se</ext-link>), the Royal Physiographical Society in Lund (to MK, SJ, OT, MJ, MS; Forssman&#x2019;s Foundation), the Sk&#xe5;ne County Council&#x2019;s research and development foundation (KR), and Swedish Research Council (KR; #2019-01053, <ext-link ext-link-type="uri" xlink:href="http://www.vr.se">www.vr.se</ext-link>). The electron microscopy was conducted at the Ume&#xe5; Centre for Electron Microscopy. Proteomic analysis was performed in Proteomics Biomedicum, Karolinska Institutet (Stockholm, Sweden).</p>
</ack>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1085908/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1085908/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atack</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Day</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Brockman</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Bakaletz</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Barenkamp</surname> <given-names>S. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The HMW2 adhesin of non-typeable <italic>Haemophilus influenzae</italic> is a human-adapted lectin that mediates high-affinity binding to 2-6 linked n-acetylneuraminic acid glycans</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>503</volume> (<issue>2</issue>), <fpage>1103</fpage>&#x2013;<lpage>1107</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2018.06.126</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avadhanula</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Ulett</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>Bakaletz</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Adderson</surname> <given-names>E. E.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression</article-title>. <source>Infect. Immun.</source> <volume>74</volume> (<issue>2</issue>), <fpage>830</fpage>&#x2013;<lpage>838</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.74.2.830-838.2006</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avila-Calderon</surname> <given-names>E. D.</given-names>
</name>
<name>
<surname>Ruiz-Palma</surname> <given-names>M. D. S.</given-names>
</name>
<name>
<surname>Aguilera-Arreola</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Velazquez-Guadarrama</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ruiz</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Gomez-Lunar</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Outer membrane vesicles of gram-negative bacteria: an outlook on biogenesis</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.557902</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berenson</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T. F.</given-names>
</name>
<name>
<surname>Wrona</surname> <given-names>C. T.</given-names>
</name>
<name>
<surname>Sethi</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Outer membrane protein P6 of nontypeable <italic>Haemophilus influenzae</italic> is a potent and selective inducer of human macrophage proinflammatory cytokines</article-title>. <source>Infect. Immun.</source> <volume>73</volume> (<issue>5</issue>), <fpage>2728</fpage>&#x2013;<lpage>2735</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.73.5.2728-2735.2005</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Jabeen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bharj</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hinks</surname> <given-names>T. S. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Non-typeable <italic>Haemophilus influenzae</italic> airways infection: the next treatable trait in asthma</article-title>? <source>Eur. Respir. Rev.</source> <volume>31</volume> (<issue>165</issue>), <page-range>1&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/16000617.0008-2022</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulieris</surname> <given-names>P. V.</given-names>
</name>
<name>
<surname>Behrens</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Holst</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Kleinschmidt</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Folding and insertion of the outer membrane protein OmpA is assisted by the chaperone skp and by lipopolysaccharide</article-title>. <source>J. Biol. Chem.</source> <volume>278</volume> (<issue>11</issue>), <fpage>9092</fpage>&#x2013;<lpage>9099</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M211177200</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calmettes</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Judd</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moraes</surname> <given-names>T. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Structural aspects of bacterial outer membrane protein assembly</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>883</volume>, <fpage>255</fpage>&#x2013;<lpage>270</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-319-23603-2_14</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrera-Salinas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gonzalez-Diaz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Calatayud</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mercado-Maza</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Puig</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Berbel</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Epidemiology and population structure of <italic>Haemophilus influenzae</italic> causing invasive disease</article-title>. <source>Microb. Genom</source> <volume>7</volume> (<issue>12</issue>), <page-range>1&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mgen.0.000723</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Henning</surname> <given-names>U.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>A periplasmic protein (Skp) of <italic>Escherichia coli</italic> selectively binds a class of outer membrane proteins</article-title>. <source>Mol. Microbiol.</source> <volume>19</volume> (<issue>6</issue>), <fpage>1287</fpage>&#x2013;<lpage>1294</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1996.tb02473.x</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Snow</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zola</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Phosphorylcholine allows for evasion of bactericidal antibody by <italic>Haemophilus influenzae</italic>
</article-title>. <source>PloS Pathog.</source> <volume>8</volume> (<issue>3</issue>), <fpage>e1002521</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002521</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duell</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Host-pathogen interactions of nontypeable <italic>Haemophilus influenzae</italic>: from commensal to pathogen</article-title>. <source>FEBS Lett.</source> <volume>590</volume> (<issue>21</issue>), <fpage>3840</fpage>&#x2013;<lpage>3853</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/1873-3468.12351</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ercoli</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Tani</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Pezzicoli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vacca</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Martinelli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pecetta</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>LytM proteins play a crucial role in cell separation, outer membrane composition, and pathogenesis in nontypeable <italic>Haemophilus influenzae</italic>
</article-title>. <source>mBio</source> <volume>6</volume> (<issue>2</issue>), <fpage>e02575</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02575-14</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erwin</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>A. L.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic>: understanding virulence and commensal behavior</article-title>. <source>Trends Microbiol.</source> <volume>15</volume> (<issue>8</issue>), <fpage>355</fpage>&#x2013;<lpage>362</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2007.06.004</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Euba</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Moleres</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Viadas</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ruiz de los Mozos</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Valle</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bengoechea</surname> <given-names>J. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Relative contribution of P5 and hap surface proteins to nontypable <italic>Haemophilus influenzae</italic> interplay with the host upper and lower airways</article-title>. <source>PloS One</source> <volume>10</volume> (<issue>4</issue>), <elocation-id>e0123154</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0123154</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Konermann</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Siu</surname> <given-names>K. W.</given-names>
</name>
<name>
<surname>Golemi-Kotra</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Diversity of penicillin-binding proteins. resistance factor FmtA of <italic>Staphylococcus aureus</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume> (<issue>48</issue>), <fpage>35143</fpage>&#x2013;<lpage>35152</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M706296200</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Calvet</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Euba</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Gil-Campillo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Catalan-Moreno</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moleres</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Marti</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Phase variation in HMW1A controls a phenotypic switch in <italic>Haemophilus influenzae</italic> associated with pathoadaptation during persistent infection</article-title>. <source>mBio</source> <volume>12</volume> (<issue>3</issue>), <fpage>e0078921</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00789-21</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fink</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>St Geme</surname> <given-names>J. W.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The <italic>Haemophilus influenzae</italic> hap autotransporter binds to fibronectin, laminin, and collagen IV</article-title>. <source>Infect. Immun.</source> <volume>70</volume> (<issue>9</issue>), <fpage>4902</fpage>&#x2013;<lpage>4907</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.70.9.4902-4907.2002</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname> <given-names>C. L. B.</given-names>
</name>
<name>
<surname>Newman</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Gillett</surname> <given-names>F. N.</given-names>
</name>
<name>
<surname>Smart</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Briggs</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Banzhaf</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A dynamic network of proteins facilitate cell envelope biogenesis in gram-negative bacteria</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>23</issue>), <page-range>1&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms222312831</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallstrom</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Blom</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Zipfel</surname> <given-names>P. F.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> protein e binds vitronectin and is important for serum resistance</article-title>. <source>J. Immunol.</source> <volume>183</volume> (<issue>4</issue>), <fpage>2593</fpage>&#x2013;<lpage>2601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0803226</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hancock</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Karunaratne</surname> <given-names>D. N.</given-names>
</name>
<name>
<surname>Bernegger-Egli</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Molecular organization and structural role of outer membrane macromolecules</article-title>. <source>New Compr. Biochem.</source> <volume>27</volume>, <fpage>263</fpage>&#x2013;<lpage>279</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0167-7306(08)60415-9</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hardison</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Wallace</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Fitch</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Heimlich</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Bryan</surname> <given-names>M. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Reprioritization of biofilm metabolism is associated with nutrient adaptation and long-term survival of <italic>Haemophilus influenzae</italic>
</article-title>. <source>NPJ Biofilms Microbiomes</source> <volume>5</volume> (<issue>1</issue>), <fpage>33</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41522-019-0105-6</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Toleman</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Villullas</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Van Alphen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Virji</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The variable P5 proteins of typeable and non-typeable <italic>Haemophilus influenzae</italic> target human CEACAM1</article-title>. <source>Mol. Microbiol.</source> <volume>39</volume> (<issue>4</issue>), <fpage>850</fpage>&#x2013;<lpage>862</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02233.x</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jalalvand</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Manat</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Chernobrovkin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kadari</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jonsson</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Protein domain-dependent vesiculation of lipoprotein a, a protein that is important in cell wall synthesis and fitness of the human respiratory pathogen <italic>Haemophilus influenzae</italic>
</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.984955</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Moon</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Gurung</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>
<italic>Acinetobacter baumannii</italic> Secretes cytotoxic outer membrane protein a <italic>via</italic> outer membrane vesicles</article-title>. <source>PloS One</source> <volume>6</volume> (<issue>2</issue>), <elocation-id>e17027</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0017027</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karalus</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T. F.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Purification and characterization of outer membrane protein P6, a vaccine antigen of non-typeable <italic>Haemophilus influenzae</italic>
</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>26</volume> (<issue>2</issue>), <fpage>159</fpage>&#x2013;<lpage>166</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-695X.1999.tb01384.x</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kemmer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Reilly</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Schmidt-Brauns</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zlotnik</surname> <given-names>G. W.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Fiske</surname> <given-names>M. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in <italic>Haemophilus influenzae</italic>
</article-title>. <source>J. Bacteriol</source> <volume>183</volume> (<issue>13</issue>), <fpage>3974</fpage>&#x2013;<lpage>3981</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.183.13.3974-3981.2001</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klaile</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Klassert</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Scheffrahn</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Heinrich</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Heyl</surname> <given-names>K. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable <italic>Haemophilus influenzae, Moraxella catarrhalis</italic>, TLR3, and type I and II interferons</article-title>. <source>Respir. Res.</source> <volume>14</volume>, <elocation-id>85</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1465-9921-14-85</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knowles</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Scott-Tucker</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Overduin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>I. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Membrane protein architects: the role of the BAM complex in outer membrane protein assembly</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>7</volume> (<issue>3</issue>), <fpage>206</fpage>&#x2013;<lpage>214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2069</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname> <given-names>H. I.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Na</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y. J.</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>Y. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Outer membrane protein a contributes to antimicrobial resistance of <italic>Acinetobacter baumannii</italic> through the OmpA-like domain</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>72</volume> (<issue>11</issue>), <fpage>3012</fpage>&#x2013;<lpage>3015</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkx257</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyriakidis</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Vasileiou</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Pana</surname> <given-names>Z. D.</given-names>
</name>
<name>
<surname>Tragiannidis</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>
<italic>Acinetobacter baumannii</italic> Antibiotic resistance mechanisms</article-title>. <source>Pathogens</source> <volume>10</volume> (<issue>3</issue>), <page-range>1&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens10030373</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langereis</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Cremers</surname> <given-names>A. J. H.</given-names>
</name>
<name>
<surname>Vissers</surname> <given-names>M.</given-names>
</name>
<name>
<surname>van Beek</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Meis</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>de Jonge</surname> <given-names>M. I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> invasive blood isolates are mainly phosphorylcholine negative and show decreased complement-mediated killing that is associated with lower binding of IgM and CRP in comparison to colonizing isolates from the oropharynx</article-title>. <source>Infect. Immun.</source> <volume>87</volume> (<issue>2</issue>), <page-range>1&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00604-18</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langereis</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>de Jonge</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Binding of human factor h to outer membrane protein P5 of non-typeable <italic>Haemophilus influenzae</italic> contributes to complement resistance</article-title>. <source>Mol. Microbiol.</source> <volume>94</volume> (<issue>1</issue>), <fpage>89</fpage>&#x2013;<lpage>106</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.12741</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leibovitz</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Dagan</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>
<italic>Haemophilus influenzae</italic>: A significant pathogen in acute otitis media</article-title>. <source>Pediatr. Infect. Dis. J.</source> <volume>23</volume> (<issue>12</issue>), <fpage>1142</fpage>&#x2013;<lpage>1152</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.inf.0000148233.57296.90</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makover</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Telep</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Penicillin-binding proteins in <italic>Haemophilus influenzae</italic>
</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>19</volume> (<issue>4</issue>), <fpage>584</fpage>&#x2013;<lpage>588</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.19.4.584</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamou</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Corona</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Cohen-Khait</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Housden</surname> <given-names>N. G.</given-names>
</name>
<name>
<surname>Yeung</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Peptidoglycan maturation controls outer membrane protein assembly</article-title>. <source>Nature</source> <volume>606</volume> (<issue>7916</issue>), <fpage>953</fpage>&#x2013;<lpage>959</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-022-04834-7</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcoux</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Politis</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rinehart</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Marshall</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Wallace</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Tamm</surname> <given-names>L. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Mass spectrometry defines the c-terminal dimerization domain and enables modeling of the structure of full-length OmpA</article-title>. <source>Structure</source> <volume>22</volume> (<issue>5</issue>), <fpage>781</fpage>&#x2013;<lpage>790</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.str.2014.03.004</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendelman</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Chaffin</surname> <given-names>D. O.</given-names>
</name>
<name>
<surname>Kalaitzoglou</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Penicillin-binding proteins and ampicillin resistance in <italic>Haemophilus influenzae</italic>
</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>25</volume> (<issue>4</issue>), <fpage>525</fpage>&#x2013;<lpage>534</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/25.4.525</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. Y.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>
<italic>Acinetobacter baumannii</italic> Outer membrane protein a modulates the biogenesis of outer membrane vesicles</article-title>. <source>J. Microbiol.</source> <volume>50</volume> (<issue>1</issue>), <fpage>155</fpage>&#x2013;<lpage>160</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12275-012-1589-4</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mychack</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Amrutha</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cardenas Arevalo</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Janakiraman</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A synergistic role for two predicted inner membrane proteins of <italic>Escherichia coli</italic> in cell envelope integrity</article-title>. <source>Mol. Microbiol.</source> <volume>111</volume> (<issue>2</issue>), <fpage>317</fpage>&#x2013;<lpage>337</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.14157</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negoda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Negoda</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Reusch</surname> <given-names>R. N.</given-names>
</name>
</person-group> (<year>2010</year>a). <article-title>Oligo-(R)-3-hydroxybutyrate modification of sorting signal enables pore formation by <italic>Escherichia coli</italic> OmpA</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1798</volume> (<issue>8</issue>), <fpage>1480</fpage>&#x2013;<lpage>1484</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamem.2009.11.023</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negoda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Negoda</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Reusch</surname> <given-names>R. N.</given-names>
</name>
</person-group> (<year>2010</year>b). <article-title>Resolving the native conformation of <italic>Escherichia coli</italic> OmpA</article-title>. <source>FEBS J.</source> <volume>277</volume> (<issue>21</issue>), <fpage>4427</fpage>&#x2013;<lpage>4437</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07823.x</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noel</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Love</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Mosser</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>High-molecular-weight proteins of nontypeable <italic>Haemophilus influenzae</italic> mediate bacterial adhesion to cellular proteoglycans</article-title>. <source>Infect. Immun.</source> <volume>62</volume> (<issue>9</issue>), <fpage>4028</fpage>&#x2013;<lpage>4033</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.62.9.4028-4033.1994</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novotny</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Bakaletz</surname> <given-names>L. O.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>The fourth surface-exposed region of the outer membrane protein P5-homologous adhesin of nontypable <italic>Haemophilus influenzae</italic> is an immunodominant but nonprotective decoying epitope</article-title>. <source>J. Immunol.</source> <volume>171</volume> (<issue>4</issue>), <fpage>1978</fpage>&#x2013;<lpage>1983</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.171.4.1978</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz-Suarez</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Samsudin</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Piggot</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Bond</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Khalid</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Full-length OmpA: structure, function, and membrane interactions predicted by molecular dynamics simulations</article-title>. <source>Biophys. J.</source> <volume>111</volume> (<issue>8</issue>), <fpage>1692</fpage>&#x2013;<lpage>1702</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bpj.2016.09.009</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Yeo</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Kumarasiri</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hesek</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane</article-title>. <source>FASEB J.</source> <volume>26</volume> (<issue>1</issue>), <fpage>219</fpage>&#x2013;<lpage>228</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.11-188425</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Behrens-Kneip</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Holst</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Kleinschmidt</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The periplasmic chaperone skp facilitates targeting, insertion, and folding of OmpA into lipid membranes with a negative membrane surface potential</article-title>. <source>Biochemistry</source> <volume>48</volume> (<issue>43</issue>), <fpage>10235</fpage>&#x2013;<lpage>10245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi901403c</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Behrens-Kneip</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Holst</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Kleinschmidt</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Binding regions of outer membrane protein a in complexes with the periplasmic chaperone skp. a site-directed fluorescence study</article-title>. <source>Biochemistry</source> <volume>48</volume> (<issue>22</issue>), <fpage>4926</fpage>&#x2013;<lpage>4936</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi9004039</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Bernstein</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T. F.</given-names>
</name>
<name>
<surname>Faden</surname> <given-names>H. S.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Binding between outer membrane proteins of nontypeable <italic>Haemophilus influenzae</italic> and human nasopharyngeal mucin</article-title>. <source>Infect. Immun.</source> <volume>64</volume> (<issue>4</issue>), <fpage>1477</fpage>&#x2013;<lpage>1479</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.64.4.1477-1479.1996</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reygaert</surname> <given-names>W. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An overview of the antimicrobial resistance mechanisms of bacteria</article-title>. <source>AIMS Microbiol.</source> <volume>4</volume> (<issue>3</issue>), <fpage>482</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3934/microbiol.2018.3.482</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ried</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hindennach</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Henning</surname> <given-names>U.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Role of lipopolysaccharide in assembly of <italic>Escherichia coli</italic> outer membrane proteins OmpA, OmpC, and OmpF</article-title>. <source>J. Bacteriol</source> <volume>172</volume> (<issue>10</issue>), <fpage>6048</fpage>&#x2013;<lpage>6053</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.172.10.6048-6053.1990</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roier</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Leitner</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Iwashkiw</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Schild-Prufert</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Feldman</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Krohne</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Intranasal immunization with nontypeable <italic>Haemophilus influenzae</italic> outer membrane vesicles induces cross-protective immunity in mice</article-title>. <source>PloS One</source> <volume>7</volume> (<issue>8</issue>), <elocation-id>e42664</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0042664</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roier</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zingl</surname> <given-names>F. G.</given-names>
</name>
<name>
<surname>Cakar</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Durakovic</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kohl</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Eichmann</surname> <given-names>T. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>A novel mechanism for the biogenesis of outer membrane vesicles in gram-negative bacteria</article-title>. <source>Nat. Commun.</source> <volume>7</volume>, <elocation-id>10515</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms10515</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronander</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Brant</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Eriksson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Morgelin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hallgren</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Westergren-Thorsson</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> adhesin protein e: characterization and biological activity</article-title>. <source>J. Infect. Dis.</source> <volume>199</volume> (<issue>4</issue>), <fpage>522</fpage>&#x2013;<lpage>531</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/596211</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosadini</surname> <given-names>C. V.</given-names>
</name>
<name>
<surname>Ram</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Akerley</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Outer membrane protein P5 is required for resistance of nontypeable <italic>Haemophilus influenzae</italic> to both the classical and alternative complement pathways</article-title>. <source>Infect. Immun.</source> <volume>82</volume> (<issue>2</issue>), <fpage>640</fpage>&#x2013;<lpage>649</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01224-13</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samsudin</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Boags</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Piggot</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Khalid</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Braun&#x2019;s lipoprotein facilitates OmpA interaction with the <italic>Escherichia coli</italic> cell wall</article-title>. <source>Biophys. J.</source> <volume>113</volume> (<issue>7</issue>), <fpage>1496</fpage>&#x2013;<lpage>1504</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bpj.2017.08.011</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samsudin</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ortiz-Suarez</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Piggot</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Bond</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Khalid</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>OmpA: a flexible clamp for bacterial cell wall attachment</article-title>. <source>Structure</source> <volume>24</volume> (<issue>12</issue>), <fpage>2227</fpage>&#x2013;<lpage>2235</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.str.2016.10.009</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>S. B.</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recurrent meningitis caused by beta-Lactamase-Positive Amoxicillin/Clavulanate-resistant non-typeable <italic>Haemophilus influenzae</italic> in a child with an inner ear malformation: a case report</article-title>. <source>Infect. Chemother.</source> <volume>53</volume> (<issue>4</issue>), <fpage>808</fpage>&#x2013;<lpage>813</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3947/ic.2020.0201</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sklar</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kahne</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Silhavy</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Defining the roles of the periplasmic chaperones SurA, skp, and DegP in escherichia coli</article-title>. <source>Genes Dev.</source> <volume>21</volume> (<issue>19</issue>), <fpage>2473</fpage>&#x2013;<lpage>2484</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.1581007</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spahich</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Kenjale</surname> <given-names>R.</given-names>
</name>
<name>
<surname>McCann</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ohashi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Erickson</surname> <given-names>H. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Structural determinants of the interaction between the <italic>Haemophilus influenzae</italic> hap autotransporter and fibronectin</article-title>. <source>Microbiol. (Reading)</source> <volume>160</volume> (<issue>Pt 6</issue>), <fpage>1182</fpage>&#x2013;<lpage>1190</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.077784-0</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Jalalvand</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Morgelin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Blom</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>
<italic>Haemophilus influenzae</italic> Acquires vitronectin <italic>via</italic> the ubiquitous protein f to subvert host innate immunity</article-title>. <source>Mol. Microbiol.</source> <volume>87</volume> (<issue>6</issue>), <fpage>1245</fpage>&#x2013;<lpage>1266</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.12164</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Jalalvand</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Thegerstrom</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The interplay between immune response and bacterial infection in COPD: focus upon non-typeable <italic>Haemophilus influenzae</italic>
</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02530</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Mattsson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Jalalvand</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T. F.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The laminin interactome: a multifactorial laminin-binding strategy by nontypeable <italic>Haemophilus influenzae</italic> for effective adherence and colonization</article-title>. <source>J. Infect. Dis.</source> <volume>220</volume> (<issue>6</issue>), <fpage>1049</fpage>&#x2013;<lpage>1060</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiz217</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hallgren</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Westergren-Thorsson</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hood</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>
<italic>Haemophilus influenzae</italic> P4 interacts with extracellular matrix proteins promoting adhesion and serum resistance</article-title>. <source>J. Infect. Dis.</source> <volume>213</volume> (<issue>2</issue>), <fpage>314</fpage>&#x2013;<lpage>323</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiv374</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thegerstrom</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Matuschek</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Riesbeck</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Resman</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A novel PBP3 substitution in <italic>Haemophilus influenzae</italic> confers reduced aminopenicillin susceptibility</article-title>. <source>BMC Microbiol.</source> <volume>18</volume> (<issue>1</issue>), <fpage>48</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-018-1196-6</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thofte</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Bettoni</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y. C.</given-names>
</name>
<name>
<surname>Thegerstrom</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jonsson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mattsson</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> P5 binds human C4b-binding protein, promoting serum resistance</article-title>. <source>J. Immunol.</source> <volume>207</volume> (<issue>6</issue>), <fpage>1566</fpage>&#x2013;<lpage>1577</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.2100105</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonnessen</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Debech</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Lindstrom</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Wester</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Skaare</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Molecular epidemiology and antibiotic resistance profiles of invasive haemophilus influenzae from Norway 2017-2021</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.973257</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Eldere</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Slack</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Ladhani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cripps</surname> <given-names>A. W.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Non-typeable <italic>Haemophilus influenzae</italic>, an under-recognised pathogen</article-title>. <source>Lancet Infect. Dis.</source> <volume>14</volume> (<issue>12</issue>), <fpage>1281</fpage>&#x2013;<lpage>1292</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1473-3099(14)70734-0</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webb</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Cripps</surname> <given-names>A. W.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Secondary structure and molecular analysis of interstrain variability in the P5 outer-membrane protein of non-typable <italic>Haemophilus influenzae</italic> isolated from diverse anatomical sites</article-title>. <source>J. Med. Microbiol.</source> <volume>47</volume> (<issue>12</issue>), <fpage>1059</fpage>&#x2013;<lpage>1067</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00222615-47-12-1059</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Shaughnessy</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ram</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Akerley</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Defining the binding region in factor h to develop a therapeutic factor h-fc fusion protein against non-typeable <italic>Haemophilus influenzae</italic>
</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2016.00040</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>